Why Biolase’s NewTom VG3 is a unique entry to the digital market

Publication
Article
dentalproductsreport.comdentalproductsreport.com-2013-04-01
Issue 4

Travis Harrison of Biolase says it’s an exciting time for Biolase and the NewTom family as the NewTom VG3 introduces a new digital imaging hybrid technology to the market.

Travis Harrison of Biolase says it’s an exciting time for Biolase and the NewTom family as the NewTom VG3 introduces a new digital imaging hybrid technology to the market.

Harrison, imaging technology manager at Biolase, took a moment during this month’s “CDA Presents” meeting in Anaheim, Calif., to demonstrate the innovative, hybrid modality of the NewTom VG3.

The hybrid modality allows practices to expand digital imaging capabilities, assess its current state, and the opportunity to venture into new areas of digital dental imaging.

All in one unit, users can produce various types of digital imaging from panoramic to CBCT and more. Watch the video below to learn more about this unique hybrid modality.

 

Related Videos
The Connected Future of Dental CAD/CAM with Max Milz
Greater New York Dental Meeting 2023 – Interview with Suzanne Cano from LunaLite Dental
Greater New York Dental Meeting 2023 – Interview with Adam McDaniel from Henry Schein One
Dental Product Insights: Midmark® Extraoral Imaging System (EOIS)
Dental Product Insights: Digital X-ray Set-Up Best Practices
Greater New York Dental Meeting 2021, Interview with Dr Alan Mead
Deep Dive: How the Dental Industry is Benefiting from Artificial Intelligence
Training Tomorrow's Dentists with Cutting Edge Technology
Related Content
© 2024 MJH Life Sciences

All rights reserved.